1 / 24

INTRACELLULAR POTASSIUM OR INTRAMOLECULAR K-DEPENDENT FUNCTION

INTRACELLULAR POTASSIUM OR INTRAMOLECULAR K-DEPENDENT FUNCTION NEW PHYSIOLOGICAL APROACH FOR DRUG DEVELOMENT IN XXI CENTURY. Prof. Antonio Delgado-Almeida A, MD, FAHA, FACC American Physiological Society, CV Section American Chemical Society

danika
Download Presentation

INTRACELLULAR POTASSIUM OR INTRAMOLECULAR K-DEPENDENT FUNCTION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. INTRACELLULAR POTASSIUM OR INTRAMOLECULAR K-DEPENDENT FUNCTION NEW PHYSIOLOGICAL APROACH FOR DRUG DEVELOMENT IN XXI CENTURY Prof. Antonio Delgado-Almeida A, MD, FAHA, FACC American Physiological Society, CV Section American Chemical Society delgado_almeida@hypertensresearch.org, med_documentos@hotmail.com Clinical Research Unit & Ion Transport Laboratory, University of Carabobo Medical School, Valencia, Venezuela

  2. Body K Physiology Body Potassium Distribution • Humans (70-Kg man) Total body K (TBK) 3700- 3800 mmol 150 mmol/L of cell water 109 ± 6 mmol/Kg of cell (AJP 2003) 96 -103 mmol/l RBC 5 mmol/l extracellular water 1 mmol/Kg W for 24-h urinary excretion Intracellular K 98 % of TBK Skeletal Muscle K (77 %), Liver (8 %) and RBC (8%), the major body K stores Extracellular K 2 % of TBK Plasma (< 0.5 %) – total K space (< 2.0 %)

  3. Body K Physiology Cell Potassium Homeostasis Factors Involved • Dietary Intake (Proteins, K, Mg, and Ca content) • Gender, Age and Ethnicity • Skeletal muscle activity • Inter-organ regulation (GI and Kidney) • Insulin, Catecholamine (Cell K uptake) • Aldosterone (Body K regulation/renal excretion • Arterial pH (Bohr’s Effect, 1905) • Pharmacological Effects Steroids, Loop Diuretics, NSAID, Potassium-Proton Pump Inhibitors, β-blockers, Cytotastic drugs and others (*)

  4. Body K Physiology Human Potassium Undefined Facts Plasma K Regulation Enteral K Absorption Body K Homeostasis

  5. RBC K and blood pH RBC K and blood pH (cell Na 6.2±1.2 mmol/l cell ) New Methods Trapped Plasma (0.8 ± 0.07%) Delgado-Almeida, Antonio Intracellular Potassium: New Concept on the Physiology and Pathophysiology of Potassium. QV277D4533, 1986: 1-71 pages. University of Carabobo Health Science Central Library (Spanish).

  6. RBC K and K Excretion RBC K and tubular K excretion following IV furosemide in Healthy Subjects Inter-Organ K Transport Delgado Almeida, Antonio. Intracellular Potassium: New Concept on the Physiology and Pathophysiology of Potassium. QV277D4533, 1986: 1-71 pages. University of Carabobo Health Science Central Library

  7. RBC K in Hypertension Bimodal Distribution on BP and RBC K MC Delgado, A Delgado Almeida. Nutr Metab and Cardiovasc Diseases. 2002 ; 12:112-116 MC Delgado, A Delgado Almeida. J Hum Hypertens. 2006; 19: 432-436

  8. RBC K in Hypertension RBC K could be a marker of K changes in other cells involved in blood pressure regulation MC Delgado, A Delgado Almeida. J Hum Hypertens. 2006; 19: 432-436 8

  9. Clinical RBC K Physiology in HT Delgado-Almeida A. Am J Hypertension. 2006; 19: 432-436

  10. Hereditable Defect in RBC K Uptake Ion Transport Studies Non-Invasive Aortic PW 248 ms 122 ms Bimodal PW Reflection in Healthy Subjects Clinical Research Unit, 2006-2012

  11. Hereditable Defect in RBC K Uptake Family Co-segregation 1992 2008 MC Delgado, A Delgado-Almeida. Abnormal Potassium. In: Advanced Therapy in Hypertension and Cardiovascular Medicine, 2006: Chapter 35

  12. Drug testing addressing Erythrocytes K Content Although many drugs were tested in our laboratory the most promising compound was 3,5-diamino-N-(diaminomethylene)-6-chloropyrazinecarboxamide hydrochloride dihydrate, amiloride hydrochloride Delgado-Almeida A. Recent Patent on Cardiovasc. Drug Discovery. 2010;5: 227.238

  13. Pharmacology Approach for RBC K transport in HT Basal Treatment 1-Month Treatment + amiloride Aortic PWA recording and analysis DynaPulse Technology, PulseMetric Inc, CA USA- 2000-2011

  14. Pharmacology Approach of Amiloride in CHD RBC K AND THE TREATMENT OF CHD Novel Physiological Approach for Reversion of Angina, ST-T Alterations and Electrical Regeneration of the Heart Delgado-Almeida A. Recent Patent on Cardiovasc. Drug Discovery.2010:5:227-238 Delgado-Almeida A, et al. Circulation 2010;122: A15761

  15. Proceeding Book Article and Online Conference 2011 Erythrocyte K t and Hb-O2 binding: a novel drug discovery for reversion of angina, ST-T alterations and the electrical regeneration of the heart in CHD Antonio Delgado-Almeida, FAHA , FACC, APS. ACS

  16. Pharmacology Approach of Amiloride in CHD AMILORIDE TIAL in Hypertension with Extensive AMI 1 2 3 4 ECG with extensive AMI and before amiloride(1). After amiloride , rapid improved ECG at 6-month (2), 1-year (3), and virtually normal at 1½ year (4)

  17. Pharmacology Approach for RBC K in CHD Improving RBC K Transport and Hemoglobin O2-binding by Amiloride: A Novel Therapeutic Approach www.Clinicaltrial.gov (NCT01228214, NCT01231165

  18. RBC Hb-K Binding In Vitro Venous Blood Oxygenation Delgado-Almeida A. From Bohr Effect to the Electrical Regeneration of the Heart FASEB J. March 29, 2012; 26:1126.7. Experimental Biology2012, April 25, 2012) Table

  19. Physiology 2009, Ellsworth ML (*) Erythrocytes(*) Oxygen Sensors and O2 delivery via ATP release for Vascular Control in CHD, Stroke, DM Erythrocytes (¶) K-Oxygen binding by Human hemoglobin Rapid pH regulation and Cell K Transport Renal K Excretion Delgado-Almeida, A (¶) “...the erythrocyte could be a novel target for the development of drugs for the treatment of vascular insufficiency"

  20. Enzyme K-binding Crystal Structure of Na+, K+ Pump K First crystal structures of Na+,K+-ATPase: new light on the oldest ion pump. Toyoshima C, et al. Structure. 2011 19(12):1732-8

  21. Potassium binding (spheres, purple); Water (red) Diagram Unrelated to Na+ exchanges First crystal structures of Na+,K+-ATPase: new light on the oldest ion pump. Toyoshima C, et al. Structure. 2011 19(12):1732-8

  22. anti-coagulant Coagulant Effects of K and Na activation of Human Thrombin Chimera

  23. New Ideas for the future David Miller, Jan 2006 I think the physiologist's experimental situation, which (usually) comprises a small piece of tissue in a large volume of bathing solution, can easily trick us (the non-clinicians like me at least) into this way of thinking. It requires special effort to bear in mind that, for most cells in most tissues, the ECF is actually a small volume surrounded by a large volume of more-or-less leaky cells! Reader in Physiology & former Director of the Graduate SchoolInstitute of Biomedical & Life SciencesUniversity of Glasgow 23

  24. THANKS YOU Prof. Delgado-Almeida A, MD FACC, FAHA, APS, ACS Prof. Antonio Javier Delgado, MD Dr. Carlos Luis Delgado-León, MD Clinical Research Unit & Ion Transport Laboratory University of Carabobo Medical School Northern Metropolitan Hospital Venezuelan Foundation of Heart Failure delgado_almeida@hypertensresearch.org med_documentos@hotmail.com

More Related